Breakthrough drug helps children with new-onset type 1 diabetes: Phase 3 trial

Children who were recently diagnosed with type 1 diabetes need less supplemental insulin to keep their blood sugar in a healthy range if they use the immunotherapy drug teplizumab, a new study reports.

Leave A Comment

Your email address will not be published. Required fields are marked *